Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the EORTC Early Clinical Study Group (ECSG)
| Autor: | Terret, C, Zanetta, S, Roché, H, Schellens, J.H.M, Faber, M.N, Wanders, J, Ravic, M, Droz, J.P |
|---|---|
| Zdroj: | In European Journal of Cancer May 2003 39(8):1097-1104 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect